Comparing mortality risk in patients with malignant melanoma and type 2 diabetes mellitus treated with immunotherapy alone versus immunotherapy plus SGLT2 inhibitors.
Authors: Muhammad Mujtaba Bhinder, Ammad Naeem, Mohammad Khudayar, Abdullah Sohail, Amir Kamran